REDUCTION OF HÆMATOCRIT AND RED-BLOOD-CELL VOLUME IN PATIENTS WITH POLYCYTHÆMIA SECONDARY TO HYPOXIC LUNG DISEASE BY DAPSONE AND PYRIMETHAMINE
- 24 December 1966
- journal article
- Published by Elsevier in The Lancet
- Vol. 288 (7478), 1381-1386
- https://doi.org/10.1016/s0140-6736(66)90421-1
Abstract
No abstract availableThis publication has 11 references indexed in Scilit:
- EFFECT OF CYCLOPHOSPHAMIDE ON LEPROSY: COMPETITIVE ACTION OF CYCLOPHOSPHAMIDE AND DAPSONEThe Lancet, 1964
- NEONATAL RESPIRATORY DISTRESS ASSOCIATED WITH A HIGH HÆMATOCRIT READINGThe Lancet, 1964
- Methemoglobinemia and Heinz Body Hemolytic Anemia Due to Phenazopyridine HydrochlorideNew England Journal of Medicine, 1964
- Dapsone-induced HaemolysisBMJ, 1963
- Pyrimethamine in the Treatment of Polycythaemia Rubra VeraBMJ, 1961
- Pyrimethamine in the Treatment of Polycythemia VeraSouthern Medical Journal, 1958
- The Use of the Isotope 51Cr as a Label for Red CellsBritish Journal of Haematology, 1955
- TREATMENT OF POLYCYTHEMIA VERA WITH DARAPRIMJAMA, 1954
- THE BODY/VENOUS HEMATOCRIT RATIO: ITS CONSTANCY OVER A WIDE HEMATOCRIT RANGEJournal of Clinical Investigation, 1953
- CIRCULATING RED CELL VOLUME MEASURED SIMULTANEOUSLY BY THE RADIOACTIVE IRON AND DYE METHODS 1Journal of Clinical Investigation, 1946